EW Healthcare Partners Mergers and Acquisitions Summary

Growth Capital Firm Profile

In the last 3 years, EW Healthcare Partners has acquired 1 company. It has also invested in 3 others.

EW Healthcare Partners’ most common sectors for investment aremedical products (41%) and life science (34%) . The Firm’s most common investment types include venture (55%) and growth capital (17%). In total, EW Healthcare Partners has invested in 16 US states and 8 different countries. Its largest (disclosed) acquisition occurred in 2004 when it acquired LipoSonix for $27M.

In the last 3 years, EW Healthcare Partners has exited 3 companies. The Firm’s most common exit type is trade sale (65%). EW Healthcare Partners’ largest (disclosed) exit occurred in 2021 when it sold Cognate BioServices for $875M.

Join Mergr to view EW Healthcare Partners’ full profile and discover more large growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity112
    • M&A Buy Activity59
    • M&A Sell Activity53
  • Total Sectors Invested 7
  • Total Countries Invested 8
  • M&A Buy/Sell Connections 58
  • M&A Advisors 4

EW Healthcare Partners

75 Rockefeller Plaza Suite 1700A,
New York, New York 10019
United States
(646) 429-1251
www.ewhealthcare.com
newyork@ewhealthcare.com

Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.


Investment Criteria

Sectors of Interest: Healthcare Services, Information Technology, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, United Kingdom

Transaction Criteria Min Max
Target Revenue 20 200
Target EBITDA - -
Investment Size 20 80
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.0/yr) # 54 1 1 2 1 - 59
vol $42M $42M
Sell (1.2/yr) # 47 3 3 - - - 53
vol $5.4B $875M $6.3B
  112

Most Recent M&A

Company Date Value Type
Boiron SA 2023-10-27 - Stake Purchase
Messimy, France · www.boiron.com
Germfree Laboratories, Inc. 2022-10-18 - Growth Capital
Ormond Beach, Florida · www.germfree.com
Grundium Oy 2022-05-05 - Stake Purchase
Tampere, Finland · www.grundium.com
Laboratoires Majorelle 2021-04-30 - Buyout (LBO, MBO, MBI)
Paris, France · www.laboratoires-majorelle.com
BreatheAmerica, Inc. 2021-03-12 - Trade Sale
Nashville, Tennessee · www.breatheamerica.com
Cognate BioServices, Inc. 2021-02-17 875M USD Trade Sale
Memphis, Tennessee · www.cognatebioservices.com
Bioventus LLC 2021-02-04 - IPO
Durham, North Carolina · www.bioventus.com
Cota, Inc. 2020-11-10 - Trade Sale
New York, New Jersey · www.cotahealthcare.com
MiMedx Group, Inc. 2020-07-02 - Stake Purchase
Marietta, Georgia · www.mimedx.com
Proteus Digital Health, Inc. 2020-06-16 - Bankruptcy
Redwood City, California · www.proteusdigitalhealth.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Medical Products 3 (30%) - 24 (41%) 27M (64%)
Life Science 6 (60%) 15M (100%) 20 (34%) 15M (36%)
Healthcare Services - - 8 (14%) -
Information Technology - - 2 (3%) -
Internet Software and Services - - 2 (3%) -
Technology Hardware 1 (10%) - 2 (3%) -
Software - - 1 (2%) -
Total 10 $15M 59 $42M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 7 (70%) 15M (100%) 50 (85%) 42M (100%)
  California 2 (20%) - 20 (34%) 27M (64%)
  Pennsylvania - - 5 (8%) -
  North Carolina 1 (10%) 15M (100%) 3 (5%) 15M (36%)
  Massachusetts - - 3 (5%) -
  Florida 2 (20%) - 2 (3%) -
  Texas 1 (10%) - 2 (3%) -
  Georgia 1 (10%) - 2 (3%) -
  Washington - - 2 (3%) -
  Tennessee - - 2 (3%) -
  New Jersey - - 2 (3%) -
  Illinois - - 2 (3%) -
  Alabama - - 1 (2%) -
  New York - - 1 (2%) -
  Minnesota - - 1 (2%) -
  Maryland - - 1 (2%) -
  Kentucky - - 1 (2%) -
France 2 (20%) - 2 (3%) -
United Kingdom - - 2 (3%) -
Finland 1 (10%) - 1 (2%) -
Canada - - 1 (2%) -
  Ontario - - 1 (2%) -
Denmark - - 1 (2%) -
Switzerland - - 1 (2%) -
Uruguay - - 1 (2%) -
Total 10 $15M 59 $42M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 2 (20%) - 32 (54%) 27M (64%)
Growth Capital 2 (20%) 15M (100%) 10 (17%) 15M (36%)
Buyout (LBO, MBO, MBI) 1 (10%) - 7 (12%) -
Stake Purchase 4 (40%) - 6 (10%) -
PIPE 1 (10%) - 2 (3%) -
Recapitalization - - 1 (2%) -
Secondary Buyout - - 1 (2%) -
Total 10 $15M 59 $42M

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 22 (42%) 4.6B (72%)
Trade Sale 13 (25%) 1.8B (28%)
IPO 12 (23%) -
Merger 3 (6%) -
Secondary Sale 2 (4%) -
Bankruptcy 1 (2%) -
Total 53 $6.3B

Top M&A Advisors

Financial Deals
PwC Corporate Finance LLC
 3
Legal Deals
Kirkland & Ellis
 4
Reed Smith
 2
Perkins Coie
 1

Deal Values

buy # Total
< $100M 2 $42M
TOTAL $42M
Largest LipoSonix, Inc.
$27M (2004-07-11)
sell # Total
$100M to $1B 18 $6.1B
< $100M 4 $260M
TOTAL $6.3B
Largest Cognate BioServices, Inc.
$875M (2021-02-17)

M&A Connections

Deals
Acquired from
Investor(s)
3%
2 (3%)
Exited to
Investor(s)
4%
2 (4%)
Strategic(s)
70%
37 (70%)

Investor Summary

Investor Type

Growth Capital Firm

Size

Large

PE Assets

3.0B USD

Established

1985

Specialist/Generalist

Specialist

Leadership

Marty Sutter

Co-Founder & Managing Director

Greg Hill

CFO & CCO

Richard Kolodziejcyk

CFO - Legacy Funds

Brooks Andrews

Managing Director

Evis Hursever

Managing Director

FAQ

When was EW Healthcare Partners founded?

EW Healthcare Partners was founded in 1985.

What type of investor is EW Healthcare Partners?

EW Healthcare Partners is a growth capital firm.

Where is EW Healthcare Partners headquartered?

EW Healthcare Partners is headquartered in New York, New York.

How much capital does EW Healthcare Partners have under management?

EW Healthcare Partners has 3.0B USD under management.

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal